Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2780 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MEDROXY | 100MG | TABLET | Resolved | 2017-10-03 | 2017-11-02 | 24268 |
| APO-MEDROXY | 100MG | TABLET | Resolved | 2020-07-29 | 2020-08-05 | 121331 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2020-09-09 | 2020-12-07 | 123944 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
| APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147302 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2022-07-22 | 2022-08-12 | 165326 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2023-01-13 | 2024-03-22 | 181101 |
| APO-MEDROXY | 100MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189671 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2023-09-01 | 2023-12-22 | 203557 |
| APO-LOXAPINE | 5MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19075 |
| APO-LOXAPINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19078 |
| APO-LOXAPINE | 25MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19081 |
| APO-LOXAPINE | 50MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19084 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-10-24 | 2018-09-11 | 26827 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-02-13 | 2018-09-10 | 39656 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-03-27 | 2018-09-11 | 44105 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-05-15 | 2018-09-15 | 49493 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-07-15 | 2018-09-15 | 55807 |
| APO-LOSARTAN | 50MG | TABLET | Resolved | 2017-03-12 | 2017-03-16 | 722 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |